A citation-based method for searching scientific literature

Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
Times Cited: 79







List of co-cited articles
524 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
116
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
22

Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
42
40



BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
E Van Riel, C C Wárlám-Rodenhuis, S Verhoef, E J T H Rutgers, M G E M Ausems. Eur J Cancer Care (Engl) 2010
40
35

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
166
17

Genetic assessment of breast cancer risk in primary care practice.
Wylie Burke, Julie Culver, Linda Pinsky, Sarah Hall, Susan E Reynolds, Yutaka Yasui, Nancy Press. Am J Med Genet A 2009
53
24

Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
Della Brown White, Vence L Bonham, Jean Jenkins, Nancy Stevens, Colleen M McBride. Cancer Epidemiol Biomarkers Prev 2008
36
33

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
87
13


Identification and referral of families at high risk for cancer susceptibility.
Kevin M Sweet, Terry L Bradley, Judith A Westman. J Clin Oncol 2002
131
13

Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
L Wideroff, S T Vadaparampil, M H Greene, S Taplin, L Olson, A N Freedman. J Med Genet 2005
111
13

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
63
17

Physician use of genetic testing for cancer susceptibility: results of a national survey.
Louise Wideroff, Andrew N Freedman, Lorayn Olson, Carrie N Klabunde, William Davis, Kadaba P Srinath, Robert T Croyle, Rachel Ballard-Barbash. Cancer Epidemiol Biomarkers Prev 2003
104
12

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
719
12

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
12


Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
12

Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics.
R T Acton, N M Burst, L Casebeer, S M Ferguson, P Greene, B L Laird, L Leviton. Acad Med 2000
114
12

Primary care physicians' use of family history for cancer risk assessment.
Brian S Flynn, Marie E Wood, Takamaru Ashikaga, Alan Stockdale, Greg S Dana, Shelly Naud. BMC Fam Pract 2010
46
19


American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
300
11


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
299
11

Attitudes and practices among internists concerning genetic testing.
Robert Klitzman, Wendy Chung, Karen Marder, Anita Shanmugham, Lisa J Chin, Meredith Stark, Cheng-Shiun Leu, Paul S Appelbaum. J Genet Couns 2013
110
11




BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
512
8

Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.
Susan A Sabatino, Ellen P McCarthy, Russell S Phillips, Risa B Burns. Cancer Detect Prev 2007
75
9


US physicians' attitudes toward genetic testing for cancer susceptibility.
A N Freedman, L Wideroff, L Olson, W Davis, C Klabunde, K P Srinath, B B Reeve, R T Croyle, R Ballard-Barbash. Am J Med Genet A 2003
134
8

Barriers in identification and referral to genetic counseling for familial cancer risk: the perspective of genetic service providers.
Sharon J Rolnick, Alanna K Rahm, Jody M Jackson, Larissa Nekhlyudov, Katrina A B Goddard, Terry Field, Catherine McCarty, Cynthia Nakasato, Douglas Roblin, Christopher P Anderson,[...]. J Genet Couns 2011
27
25

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
116
8

Cancer genetic risk assessment and referral patterns in primary care.
Hetal S Vig, Joanne Armstrong, Brian L Egleston, Carla Mazar, Michele Toscano, Angela R Bradbury, Mary B Daly, Neal J Meropol. Genet Test Mol Biomarkers 2009
46
15

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
39
17

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
64
10

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
45
15

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
362
8


The comprehensiveness of family cancer history assessments in primary care.
Harvey J Murff, Robert A Greevy, Sapna Syngal. Community Genet 2007
78
7

Genetic/familial high-risk assessment: breast and ovarian.
Mary B Daly, Jennifer E Axilbund, Saundra Buys, Beth Crawford, Carolyn D Farrell, Susan Friedman, Judy E Garber, Salil Goorha, Stephen B Gruber, Heather Hampel,[...]. J Natl Compr Canc Netw 2010
166
7

Barriers to and motivations for physician referral of patients to cancer genetics clinics.
Carrie F Prochniak, Lisa J Martin, Erin M Miller, Sara C Knapke. J Genet Couns 2012
26
23


Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
194
7

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
153
7

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
74
8

A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
Tilley Jenkins Vogel, Kyrsten Stoops, Robin L Bennett, Margaret Miller, Elizabeth M Swisher. Gynecol Oncol 2012
16
37

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.
Anne Marie McCarthy, Mirar Bristol, Tracey Fredricks, Lache Wilkins, Irene Roelfsema, Kaijun Liao, Judy A Shea, Peter Groeneveld, Susan M Domchek, Katrina Armstrong. Cancer 2013
17
35


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.